M Praga

Summary

Publications

  1. ncbi [The treatment of focal and segmentary glomerulosclerosis]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 25:612-4, 616-8, 620-1. 2005
  2. ncbi Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
    Enrique Morales
    Division of Nephrology, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Spain
    Nephrol Dial Transplant 28:405-12. 2013
  3. ncbi Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy
    Manuel Praga
    Nephrology Division, Hospital 12 de Octubre, Avenida de Cordoba s n, 28041 Madrid, Spain
    Nat Rev Nephrol 8:496-8. 2012
  4. ncbi Hepatitis C-induced renal disease in patients with AIDS: an emergent problem
    Manuel Praga
    Nephrology Division, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
    Contrib Nephrol 176:24-34. 2012
  5. ncbi Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial
    Manuel Praga
    Hospital 12 de Octubre, Madrid, Hospital Virgen del Rocio, Sevilla, Hospital Gregorio Maranon, Madrid, Spain
    Nephrol Dial Transplant 18:1806-13. 2003
  6. ncbi Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial
    Manuel Praga
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    J Am Soc Nephrol 14:1578-83. 2003
  7. ncbi Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial
    M Praga
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid, Spain
    Kidney Int 71:924-30. 2007
  8. ncbi Weight loss and proteinuria
    Manuel Praga
    Servicio de Nefrologia, Hospital Universitario 12 de Octubre, Madrid, Spain
    Contrib Nephrol 151:221-9. 2006
  9. ncbi [Prevention of renal failure beyond arterial HT and diabetes mellitus control]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 25:78-81. 2005
  10. ncbi Obesity, proteinuria and progression of renal failure
    Manuel Praga
    Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
    Curr Opin Nephrol Hypertens 15:481-6. 2006

Collaborators

Detail Information

Publications73

  1. ncbi [The treatment of focal and segmentary glomerulosclerosis]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 25:612-4, 616-8, 620-1. 2005
  2. ncbi Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases
    Enrique Morales
    Division of Nephrology, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Spain
    Nephrol Dial Transplant 28:405-12. 2013
    ....
  3. ncbi Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy
    Manuel Praga
    Nephrology Division, Hospital 12 de Octubre, Avenida de Cordoba s n, 28041 Madrid, Spain
    Nat Rev Nephrol 8:496-8. 2012
    ..The availability of a validated biomarker that is easy to measure and able to accurately predict long-term outcomes would be very helpful for tailoring treatment of the disease to the individual...
  4. ncbi Hepatitis C-induced renal disease in patients with AIDS: an emergent problem
    Manuel Praga
    Nephrology Division, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
    Contrib Nephrol 176:24-34. 2012
    ..Information about the effect of specific anti-VHC therapy or immunosuppressive agents in these patients is very limited...
  5. ncbi Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial
    Manuel Praga
    Hospital 12 de Octubre, Madrid, Hospital Virgen del Rocio, Sevilla, Hospital Gregorio Maranon, Madrid, Spain
    Nephrol Dial Transplant 18:1806-13. 2003
    ..Angiotensin II receptor antagonists are renoprotective in patients with type 2 diabetes, but studies about their effect in non-diabetic proteinuric nephropathies are very scarce...
  6. ncbi Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial
    Manuel Praga
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    J Am Soc Nephrol 14:1578-83. 2003
    ..001 between groups). In conclusion, ACE inhibitors significantly improve renal survival in proteinuric IgAN with normal or moderately reduced renal function...
  7. ncbi Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial
    M Praga
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid, Spain
    Kidney Int 71:924-30. 2007
    ..The majority of patients experienced remission with a significant reduction in the risk for deteriorating renal function...
  8. ncbi Weight loss and proteinuria
    Manuel Praga
    Servicio de Nefrologia, Hospital Universitario 12 de Octubre, Madrid, Spain
    Contrib Nephrol 151:221-9. 2006
    ....
  9. ncbi [Prevention of renal failure beyond arterial HT and diabetes mellitus control]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 25:78-81. 2005
  10. ncbi Obesity, proteinuria and progression of renal failure
    Manuel Praga
    Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
    Curr Opin Nephrol Hypertens 15:481-6. 2006
    ..Recent studies have reported an alarming increase in the incidence of obesity-related glomerulopathy, in a context of a worldwide spread of obesity...
  11. ncbi [The treatment of membranous glomerulonefritis]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 25:467-70, 472-4. 2005
  12. ncbi Acute interstitial nephritis
    Manuel Praga
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Kidney Int 77:956-61. 2010
    ..Delayed steroid treatment, when interstitial fibrosis has taken place, would have a less pronounced or nule therapeutic benefit...
  13. ncbi Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration
    M Praga
    Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain
    Am J Kidney Dis 33:52-8. 1999
    ..In conclusion, patients with FSG secondary to hyperfiltration do not develop hypoalbuminemia or the other characteristic complications of nephrotic syndrome, despite the presence of massive proteinuria values...
  14. ncbi Obesity-related renal damage: changing diet to avoid progression
    Manuel Praga
    Department of Nephrology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain
    Kidney Int 78:633-5. 2010
    ..The relationship between diet and renal hemodynamics in obesity is complex, and more studies (including ones on the effect of caloric restriction) are needed...
  15. ncbi Familial microscopic hematuria caused by hypercalciuria and hyperuricosuria
    M Praga
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Am J Kidney Dis 35:141-5. 2000
    ..Determination of calcium and uric acid urinary excretions should be included in the study of familial hematuria...
  16. ncbi Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy
    M Praga
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Kidney Int 58:2111-8. 2000
    ..Some patients develop proteinuria and progressive renal failure after unilateral nephrectomy, although the majority of patients maintain normal renal function. Reasons to explain this different evolution are not known...
  17. ncbi Everolimus represents an advance in immunosuppression for patients who have developed cancer after renal transplantation
    E Gonzalez
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2332-3. 2009
    ..The results suggested that immunosuppression with everolimus combined with low doses of CNIs or in single-drug therapy is safe immunosuppression for patients who develop posttransplant malignant diseases...
  18. ncbi Obesity favors surgical and infectious complications after renal transplantation
    B Espejo
    Nephrology Department, 12 de Octubre Hospital, Madrid, Spain
    Transplant Proc 35:1762-3. 2003
    ..05) and wound infections (12.5%) posttransplant with similar incidences of wound dehiscence, perigraft collections, and graft function at the end of follow up...
  19. ncbi Compative study of bladder versus enteric drainage in pancreas transplantation
    C Jiménez-Romero
    Servicio de Cirugía General y Trasplante de Organos Abdominales, Hospital Doce de Octubre, Madrid, Spain
    Transplant Proc 41:2466-8. 2009
    ..There is some controversy concerning the choice of best technique for drainage of exocrine secretions in pancreas transplantation. We compared patients with bladder drainage (BD) versus those with enteric drainage (ED)...
  20. ncbi Extended-release tacrolimus therapy in de novo kidney transplant recipients: single-center experience
    A Andres
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 42:3034-7. 2010
    ..Available data for extended-release tacrolimus (Tac) except in clinical trials are limited...
  21. ncbi [Antiproteinuric effect of renin-angiotensin system blockade in patients with normal/lower than 115 mmHg systolic blood pressure]
    E Gutierrez
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid
    Nefrologia 24:546-52. 2004
    ..CONCLUSIONS: RAAS blockade by ACEI/ARA induces a significant antiproteinuric and renoprotective effect in proteinuric patients with normal/low levels of BP Initial doses of ACEI/ARA were well tolerated...
  22. ncbi Kidneys from elderly deceased donors discarded for transplantation
    A Andres
    Coordinación de Trasplantes and Servicios de Nefrologia and Urologia, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2379-81. 2009
    ....
  23. ncbi [Atheroembolic renal disease: analysis of clinical and therapeutic factors that influence its progression]
    Elena Gutierrez Solis
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid
    Nefrologia 30:317-23. 2010
    ..Renal and individual outcome is poor, but some patients have spontaneous recovery of renal function. Renal survival was significantly better in spontaneous disease. We don t observe beneficial effect of steroid treatment...
  24. ncbi Survival of patients older than 60 years with kidneys transplanted from Spanish expanded criteria donors versus patients continued on hemodialysis
    J Martín Navarro
    S Nefrología Hospital Universitario 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2376-8. 2009
    ..According to our data, elderly patients with low comorbidity should be considered for inclusion on the WL for transplantation...
  25. ncbi Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months
    E González Monte
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 42:2899-901. 2010
    ..Therefore, it is suggested that using triple blockade of RAS is feasible in selected renal transplant patients to reduce proteinuria, although caution is required to avoid severe hyperkalemia...
  26. ncbi Long-term results of renal transplantation in elderly cadaver donor recipients 65 years old or older
    A Andres
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 34:356-7. 2002
  27. ncbi Results of kidney transplantation in recipients over 70 years of age: experience at a single center
    J C Herrero
    Nephrology Service, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 35:1675-6. 2003
    ..5%, 86%, and 68%, respectively. Nine of the 18 graft losses were due to recipient death. Overall, renal transplant recipients >70 years showed good results. The principal cause of graft loss was recipient death...
  28. ncbi Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients
    J M Morales
    Renal Transplant Unit, Nephrology Department, Doce de Octubre Hospital, Madrid, Spain
    Transplant Proc 37:3738-42. 2005
    ..9 +/- 1.3 ng/mL. In summary, our results suggest that Tac-based immunosuppression provides an excellent kidney function 10 years after transplantation and allows monotherapy in a high percentage of kidney transplant patients...
  29. ncbi Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab
    S Alexandru
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2435-7. 2009
    ..Our study suggests that immunosuppressant monotherapy with Rapamycin is safe and efficient for renal recipients who develop lymphoma because of its antitumor effects without nephrotoxicity...
  30. ncbi Conversion from bladder to enteric drainage for complications after pancreas transplantation
    C Jiménez-Romero
    Servicio di Cirugía General, Hospital Doce de Octubre, Madrid, Spain
    Transplant Proc 41:2469-71. 2009
    ..Bladder drainage (BD) of exocrine secretions is associated with urological and pancreatitis complications. Herein we have analyzed our experience with conversion from BD to enteric drainage (ED)...
  31. ncbi Renal transplantation in emigrants from Africa in Spain: similar results but different infectious profile compared with Spanish people
    E Mérida
    Nephrology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2363-5. 2009
    ..However, these patients needed higher doses of Tacrolimus and experienced more rare opportunistic infections...
  32. ncbi Mycophenolate mofetil immunosuppressive therapies increase the incidence of cytomegalovirus infection in renal transplantation
    M A Munoz
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 34:97. 2002
  33. ncbi A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function
    Amado Andres
    Nephrology Service, Hospital 12 de Octubre, Madrid, Spain
    Clin Transplant 23:23-32. 2009
    ..Late onset group did not achieve improvement in DGF rate and showed a higher incidence of clinically treated and biopsy-proven acute rejection...
  34. ncbi Helical computed tomography angiography is the most efficient test to assess vascular calcifications in the iliac arterial sector in renal transplant candidates
    A Andres
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 35:1682-3. 2003
    ....
  35. ncbi [Immunoallergic interstitial nephritis vs. cholesterol atheroembolism. Differentiating characteristics]
    B Espejo
    , Hospital 12 de Octubre, , s/n. 28041 Madrid
    Nefrologia 23:125-30. 2003
    ..In summary, the analysis of clinical and laboratory data allows an initial differential diagnosis in patients suspected as having IIN or ATD...
  36. ncbi Lower rate of family refusal for organ donation in non-heart-beating versus brain-dead donors
    A Andres
    Hospital Universitario 12 de Octubre, Madrid, Spain
    Transplant Proc 41:2304-5. 2009
    ..We examined whether the type of potential donor, that is brain-dead or non-heart-beating, had an influence on family refusal. In July 2005, we initiated a program of non-heart-beating donors who had died in the street or at home...
  37. ncbi [Relapsing nephrotic syndrome in a diabetic patient with minimal change]
    J A Garcia Donaire
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid
    Nefrologia 24:179-82. 2004
    ..An 8-weeks cycle of steroids plus chlorambucil induced a complete and persistent remission. Throughout a five-year follow up, no relapse of the nephrotic syndrome was observed and microalbuminuria is negative...
  38. ncbi Incidence of pancreas graft thrombosis in portoiliac and portocaval venous anastomosis
    C Jimenez
    Servicio de Cirugia General, Ap Digestivo y Trasplante de Organos Abdominales, Madrid, Spain
    Transplant Proc 37:3977-8. 2005
    ..Pancreas graft thromboses represent more than 70% of all technical failures; multiple risk factors have been implicated. We analyzed the thrombosis rates using portoiliac versus portocaval vein anastomoses...
  39. ncbi Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis
    E Gonzalez
    Hospital 12 de Octubre, Madrid, Spain
    Kidney Int 73:940-6. 2008
    ..Our study shows that steroids should be started promptly after diagnosis of DI-AIN to avoid subsequent interstitial fibrosis and an incomplete recovery of renal function...
  40. ncbi Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis
    M Praga
    Department of Nephrology, Hospital Universitario 12 de Octubre, Carretera de Andalucia, km 5, 400, E-28041 Madrid, Spain
    Nephrol Dial Transplant 16:1790-8. 2001
    ....
  41. ncbi Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients
    J M Morales
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Am J Transplant 10:2453-62. 2010
    ..HCVD+ was not a significant risk factor for mortality, graft failure and liver disease among HCVR+. These data strongly suggest that the use of kidneys from HCVD+ in HCVR+ is a safe long-term strategy that helps to prevent kidney loss...
  42. ncbi [Acute hyperphosphatemia secondary to phosphate administration for bowel preparation]
    E Gutierrez
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid
    Nefrologia 24:283-7. 2004
    ..The phosphate cathartics are contraindicated in patients with severe renal insufficient or in dialysis program. Our case shows the severe side effects secondary to injudicious use of sodium phosphate cathartics...
  43. ncbi Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function
    E Gonzalez
    Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 37:3736-7. 2005
    ....
  44. ncbi Results of a living donor kidney promotion program
    E González Monte
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 42:2837-8. 2010
    ..Due to the high rate of cadaveric donation in Spain, there has only been a limited increase in the number of living donor kidney transplantations...
  45. ncbi Encrusted pyelitis and cystitis by Corynebacterium urealyticum (CDC group D2): a new and threatening complication following renal transplant
    J M Aguado
    Infectious Diseases Unit, Hospital 12 de Octubre, Universidad Complutense, Madrid, Spain
    Transplantation 56:617-22. 1993
    ..EP and EC could lead to the loss of their grafts. C urealyticum appears to have a pathogenic role in these entities...
  46. ncbi [The antiproteinuric effect of the blockage of the renin-angiotensin-aldosterone system (RAAS) in obese patients. Which treatment option is the most effective? ]
    E Morales
    Servicio de Nefrologia, Hospital Universitario 12 de Octubre, Madrid, Spain
    Nefrologia 29:421-9. 2009
    ..No studies have compared the efficacy of the currently available antiproteinuric strategies (ACE inhibitors -ACEI-, angiotensin receptor blockers -ARB-, aldosterone antagonists) in obese patients with proteinuric renal diseases...
  47. ncbi Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications
    J C Herrero
    Nephrology and Urology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 34:96. 2002
  48. ncbi Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition
    M Praga
    Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain
    Am J Kidney Dis 17:330-8. 1991
    ..1 +/- 2.4 to 8.8 +/- 4 g/d). Serum creatinine (Scr) remained stable during captopril treatment in group I, whereas three patients in group II showed a worsening of renal function.(ABSTRACT TRUNCATED AT 250 WORDS)..
  49. ncbi [Digestive haemorrhage due to angiodysplasia in dialysis patients. Treatment with conjugated estrogens]
    M J Manzanera
    , Hospital Doce de Octubre, Madrid
    Nefrologia 25:412-5. 2005
    ..This type of non-invasive treatment can avoid aggressive therapeutic interventions in patients with a high prevalence of co-morbid conditions (old patients undergoing chronic dialysis)...
  50. ncbi [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil]
    B Noroña
    Servicio de Nefrologia, Hospital 12 de Octubre, Madrid
    Nefrologia 24:79-82. 2004
    ..The introduction of mycophenolate mofetil (500-15,000 mg/day) was followed by a sustained complete remission in both cases, without secondary effects...
  51. ncbi [Vascular access models cause heterogeneous results in the centres of one community]
    E Gruss
    Servicio de Nefrologia, Hospital Universitario Fundacion Alcorcon, Alcorcon, Madrid
    Nefrologia 30:310-6. 2010
    ..Vascular access (VA) is the main difficulty in our hemodialysis Units and there is not adequate update data in our area...
  52. ncbi Spontaneous improvement of the renal function in a patient with HIV-associated focal glomerulosclerosis
    Enrique Morales
    Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain
    Am J Nephrol 22:369-71. 2002
    ..There is no proven effective therapy for HIVAN, and the majority of the patients become dialysis dependent. We report a case of biopsy-proven HIVAN that showed spontaneous improvement of the renal function...
  53. ncbi Malignant hypertension in HIV-associated glomerulonephritis
    Enrique Morales
    Servicio de Nefrologia, Hospital 12 de Octubre, Avda, Andalucía s n, 28041 Madrid, Spain
    Nephrol Dial Transplant 23:3901-7. 2008
    ..We have observed several HIV patients with glomerulonephritis in whom malignant hypertension (MHT) was the first clinical manifestation...
  54. ncbi Unilateral pleural effusions associated with stenoses of left brachiocephalic veins in haemodialysis patients
    Enrique Morales Ruiz
    Department of Nephrology, Hospital Universitario, Madrid, Spain
    Nephrol Dial Transplant 20:1257-9. 2005
  55. ncbi Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses
    Juliá Segura
    Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid, 28041, Spain
    J Renin Angiotensin Aldosterone Syst 4:43-7. 2003
    ..Both ACE-I and ARB were titrated as monotherapy up to the maximal recommended dose...
  56. ncbi Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy
    Eduardo Gutierrez
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Clin J Am Soc Nephrol 2:51-7. 2007
    ..Duration of MH longer than 10 d, age >50 yr, decreased baseline eGFR, absence of previous episodes of MH, and the severity of tubular necrosis were significant risk factors for an incomplete recovery of renal function...
  57. ncbi Chronic kidney disease as a situation of high added risk in hypertensive patients
    Julian Segura
    Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, 28041 Madrid, Spain
    J Am Soc Nephrol 17:S136-40. 2006
    ..This paper briefly reviews the most recent evidences about pharmacologic therapies in high-risk patients, focusing on benefits related to improvement of cardiovascular risk factors in hypertensive patients with chronic kidney disease...
  58. ncbi Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney
    Ester González
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Kidney Int 68:263-70. 2005
    ....
  59. ncbi Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies
    Enrique Morales
    Departments of Nephrology and Endocrinology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Am J Kidney Dis 41:319-27. 2003
    ..05). Conclusion: Moderate weight loss in overweight patients with chronic proteinuric nephropathies induces a significant decrease in proteinuria. Am J Kidney Dis 41:319-327...
  60. ncbi Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials
    Gema Fernández-Juárez
    Department of Nephrology, Fundacion Hospital Alcorcon, C Budapest 1 Alcorcon, Madrid 28922, Spain
    J Am Soc Nephrol 17:S250-4. 2006
    ....
  61. ncbi Influence of expanding donor age on the allocation of kidneys for transplantation
    A Andres
    Transplant Coordination Unit and Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    Transplant Proc 34:15-6. 2002
  62. ncbi [Familial benign hematuria]
    M Praga
    , Hospital 12 de Octubre, Madrid
    Nefrologia 23:40-5. 2003
  63. ncbi Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis
    Gema Fernandez-Fresnedo
    Department of Nephrology, Hospital Marques de Valdecilla, Santander, Spain
    Clin J Am Soc Nephrol 4:1317-23. 2009
    ..Isolated case reports have shown a beneficial effect of rituximab on pediatric patients with primary FSGS, but there is no information about rituximab treatment of FSGS in adults...
  64. ncbi Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study
    Alfons Segarra
    Servicio de Nefrologia, Anexo planta 7, Hospital Vall d Hebron, Paseo Valle Hebrón 119 129, Barcelona 08035, Spain
    Nephrol Dial Transplant 22:1351-60. 2007
    ..Studies of mycophenolate mofetil (MMF) in primary glomerulonephritis have varied in their inclusion criteria, regimen and follow-up compromising assessments of efficacy and optimal dose...
  65. ncbi [Immunosuppressive therapy of primary focal sclerosing glomerulonephritis in the adult: a systematic review]
    C Quereda
    , , Madrid, Spain
    Nefrologia 27:249-60. 2007
  66. ncbi Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy
    Alvaro Torres
    Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
    Kidney Int 61:219-27. 2002
    ..Untreated patients progressed without exception toward advanced renal failure...
  67. ncbi Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy
    Natalia Polanco
    Hospital 12 de Octubre, Madrid, Spain
    J Am Soc Nephrol 21:697-704. 2010
    ..A decrease in proteinuria >50% from baseline during the first year predicts spontaneous remission...
  68. ncbi Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome?
    Julian Segura
    Hypertension Unit, Nephrology Department, Hospital 12 de Octubre, Madrid, Spain
    J Clin Hypertens (Greenwich) 9:595-600. 2007
    ..Global CV risk, however, remained higher in MS patients, as suggested by a 3-fold higher incidence of new-onset diabetes (absolute increase of 5.6%) and a 2-fold increase in microalbuminuria...
  69. ncbi The reno-protective effect of the dual blockade of the renin angiotensin system (RAS)
    José Luño
    Hospital General Universitario Gregorio Maranon, C Dr Esquerdo 46, 28007 Madrid, Spain
    Curr Pharm Des 11:1291-300. 2005
    ..Long-term clinical trials are needed and encouraged to further establish the significant role of dual blockade in renal protection particularly in diabetic nephropathy...
  70. ncbi Blood pressure control in patients with chronic renal insufficiency in Spain: a cross-sectional study
    Rafael Marín
    Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
    J Hypertens 24:395-402. 2006
    ..The present study was designed for assessment of control rates of blood pressure in patients with CRI. Secondary objectives included evaluation of the control rates of proteinuria and cardiovascular comorbidities...
  71. ncbi Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy
    Manuel Praga
    Nephrol Dial Transplant 20:2594-7. 2005
  72. ncbi Obesity--a neglected culprit in renal disease
    Manuel Praga
    Nephrol Dial Transplant 17:1157-9. 2002
  73. ncbi Relapse of lupus nephritis more than 10 years after complete remission
    Ana Carlavilla
    Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain
    Nephrol Dial Transplant 20:1994-8. 2005